Wen Wang1, Yunjia Jiao2, Xiaojing Du3

  • 1Zhejiang University, Hangzhou, Zhejiang 310058, China; Department of Orthopedics, Fenghua People's Hospital, 36 Gongyuan Road, Ningbo, Zhejiang 315502, China; Department of Orthopedics, Musculoskeletal Tumor Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.

Gene
|October 6, 2024
PubMed
概括

这项研究确定了与免疫相关的糖化基因 (IRGGs),这些基因可以预测骨髓瘤的预后并指导治疗. 一个6基因风险评分有效地对免疫疗法或MEK抑制剂治疗的患者进行分层.